NCT03316144 2020-09-30Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Toripalimab for Patients With Recurrent Malignant LymphomaShanghai Junshi Bioscience Co., Ltd.Phase 1 Completed13 enrolled